Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements

Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements The only amendment related to post-market regulation is the Minister’s new (continued) authority to impose terms and conditions for a designated COVID-19 drug (C.01.014.21). 2021-07-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemicCOVID-19 drugamendementFood and Drug Regulationsdrugsmanufacturerssubmissionnotice of compliancepost-market regulationsMinister’s authority Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirementsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/food-drug-regulations-amendments-covid-19/post-market-requirements.html Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirementsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/reglement-aliments-drogues-modifications-covid-19/exigences-posterieures-mise-en-marche.html

The only amendment related to post-market regulation is the Minister’s new (continued) authority to impose terms and conditions for a designated COVID-19 drug (C.01.014.21).

Data and Resources

Similar records